DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
A phase 4 unequal randomization, double blind study to evaluate the dose tolerance and safety
of extended release Equetro (carbamazepine) versus placebo followed by an Open label and long
term maintenance treatment in children and adolescents aged 10-17 years diagnosed with acute
manic or mixed Bipolar I Disorder